Search research articles
Contact Us
Filters
Showing results (101-110 of 103) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 103 results.
Clinical Biochemistry
|
February 15, 2026
Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC)
Victoria Higgins, Michelle L Parker, Basma Ahmed, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis
Jörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Journal of the American Medical Directors Association
|
November 25, 2017
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Dionne E Smid, Frits M E Franssen, Maria Gonik, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 103) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 103 results.
Clinical Biochemistry
|
February 15, 2026
Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC)
Victoria Higgins, Michelle L Parker, Basma Ahmed, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis
Jörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Journal of the American Medical Directors Association
|
November 25, 2017
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Dionne E Smid, Frits M E Franssen, Maria Gonik, et al.
Page
of 11